NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Testicular Cancer. These NCCN Guidelines™ are currently available as Version 2.2010.
The TNM Staging System for Testicular Cancer has been updated based on the 7th edition of the American Joint Committee on Cancer (AJCC) Staging Manual.
The Discussion section of the NCCN Guidelines™ for Testicular Cancer has also been updated.
NCCN has published the following updates to the Neuroendocrine Tumors chapter of the NCCN Drugs & Biologics Compendium (NCCN Compendium™) to reflect updates to the 2010 version of the corresponding NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™):
Everolimus and sunitinib have been added to the list of agents used in the management of metastatic islet cell tumors, both with a category 2B designation.